Article
EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system.
International journal of clinical oncology - 1 Mar 2024
Nomura Kotaro, Aokage Keiju, Kaminuma Yasunori, Nakai Tokiko, Wakabayashi Masashi, Ikeno Takashi, Koike Yutaro, Taki Tetsuro, Miyoshi Tomohiro, Tane Kenta, Samejima Joji, Ishii Genichiro, Tsuboi Masahiro
Abstract excerpt
INTRODUCTION: The developments of perioperative treatments for patients with high-risk early-stage lung cancer are ongoing, however, real-world data and evidence of clinical significance of genetic aberration are lacking in this population. This study aimed to identify patients with early-stage lung adenocarcinoma at high risk for recurrence based on pathological indicators of poor prognosis, including the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.